© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
July 7th 2021, 6:00pm
Results demonstrating the efficacy of Bavencio highlight the importance of incorporating recent clinical trial successes into the treatment conversation.
June 28th 2021, 3:00pm
Opdivo was the first PD-1 inhibitor to show durable responses in patients with esophageal squamous cell carcinoma.
June 15th 2021, 6:00pm
Treatment with pyrotinib and the chemotherapies trastuzumab, docetaxel and carboplatin significantly improved response rates over the triplet chemotherapy regimen alone in the neoadjuvant treatment of patients with HER2-positive breast cancer.
June 9th 2021, 3:00pm
The data, according to the study’s lead author, confirm that Trodelvy should be considered a new standard of care in patients with metastatic triple-negative breast cancer.
June 8th 2021, 5:00pm
Patients with early triple-negative breast cancer receiving Imfinzi in addition to neoadjuvant chemotherapy saw increased survival rates and complete responses to treatment.
June 7th 2021, 6:30pm
The treatment was also associated with antitumor activity in patients with metastatic castration-resistant prostate cancer.
June 7th 2021, 2:30pm
Responses to the study drug, according to one of the study’s authors, appeared far superior than what would have been expected with other treatments in patients with HER2-expressing metastatic colorectal cancer.
June 7th 2021, 1:00pm
The long-term follow-up data, according to one of the study’s authors from the Sarah Cannon Cancer Institute, demonstrate “a new benchmark for the standard of care” in the treatment of patients with unresectable stage 3 non-small cell lung cancer.
June 7th 2021, 12:00pm
Treatment with aumolertinib was associated with prolonged survival in patients with advanced non-small cell lung cancer.
June 6th 2021, 8:00pm
After long-term follow-up, the CAR-T cell therapy still boosted survival outcomes in patients with relapsed/refractory multiple myeloma, regardless of the number of prior lines of therapy received.
Inaccurate Information on Cancer Diagnosis and Treatment Common on Social Media Sites
Small-Town Cancer Team, Big Success
Grief Is Like Swimming
Rick Aiello Dies From Pancreatic Cancer, FDA Approves First Drug to Treat Lymphoma in Dogs and More